Rice University scientists create electrical protein switches triggered by chemicals
Scientists at Rice University have developed synthetic protein switches to control the flow of electrons.
The proof-of-concept, metal-containing proteins made in the Rice lab of synthetic biologist Joff Silberg are expressed within cells upon the introduction of one chemical and are functionally activated by another chemical. If the proteins have been placed in the cell, they can simply be turned on and off.
“This is not a metaphor for a switch, it is a literal electrical switch built from a protein,” Silberg said.
The proteins could facilitate next-generation bioelectronics, including complete biological circuits within cells that mimic their electronic counterparts. The possible applications include living sensors, electronically controlled metabolic pathways for chemical synthesis and active pills that sense their environment and release drugs only when needed.
The work appears in Nature Chemical Biology.
“Biology is really good at sensing molecules,” said Silberg, a professor of biosciences and bioengineering. “That’s an amazing thing. Think about how complex the cell is, and how proteins evolve that can respond to a single prompt in a sea of information. We want to leverage that exquisite ability to build more elaborate biomolecules and use these to develop useful synthetic biology technologies.”
The Rice team takes advantage of those innate abilities. “Natural proteins that move electrons more or less act as wires that are always there,” said Systems, Synthetic, and Physical Biology graduate student and lead author Josh Atkinson. “If we can turn these pathways on and off, we can make cells operate more efficiently.”
Rice’s metalloprotein switches – so called for their iron content – are quick, Silberg said. Nature typically controls electron flow by using genetic mechanisms to control the production of the protein “wires.”
“It’s all transcriptional,” he said. “Even in a fast-growing E. coli bacteria, it takes many minutes. By contrast, protein switches function on a time scale of seconds.”
To make the switch – which they use in a synthetic electron transfer pathway – the researchers needed a stable protein that could be reliably split along its peptide backbone to allow for the insertion of protein fragments that complete or break the circuit. They based the switch on ferredoxin, a common iron-sulfur protein that mediates electron transfer in all the domains of life.
Atkinson built switches embedded in E. coli that can be turned on in the presence (or off in the absence) of 4-hydroxytamoxifen, an estrogen receptor modulator used to fight breast and other cancers, or by bisphenol A (BPA), a synthetic chemical used in plastics.
Their E. coli bacterium is a mutant strain that is programmed to only grow in a sulfate medium when all of the components of the ferredoxin electron transport chain – including electron donor and acceptor proteins – are expressed. That way, the bacteria could only grow if the switches turn on and transfer electrons as planned.
Silberg said the discovery should lead to custom-designed switches for many applications, including contact with external electronic devices. “It’s why we’ve been so gung-ho about this idea of bioelectronics, a whole field that’s emerging as synthetic biology gets more control over the design,” he said. “Once you can standardize this, there are all kinds of things we can build with cells.”
That could include smart pills that release medications only on demand, or gut biome detectors that report on conditions. Or perhaps electrical circuits contained entirely within cells.
“We can already map a lot of what electrical engineers do with capacitors and resistors onto metabolism, but until now, there have been no switches,” Silberg said.
He suggested multiple switches could also turn a cell into a biological processor. “Then we could see digital parallel processing in the cell,” he said. “It changes the way we look at biology.”
Learn more: Switch-in-a-cell electrifies life
The Latest on: Bioelectronics
via Google News
The Latest on: Bioelectronics
- BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain on May 22, 2019 at 8:45 am
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today ... […]
- Bioelectronics and Biosensors Market to Witness Huge Growth by 2025 | Bayer, Abbott Point of Care, F. Hoffmann-La Roche on May 21, 2019 at 4:40 am
May 21, 2019 (HTF Market Intelligence via COMTEX) -- HTF MI released a new market study on Global Bioelectronics and Biosensors Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread ... […]
- Key Executives for BioElectronics Corporation on May 16, 2019 at 5:35 pm
Only a company representative may request an update for the company profile. Documentation will be required. To contact BioElectronics Corporation, please visit . Company data is provided by S&P ... […]
- Bioelectronics and Biosensors Market Research 2019, Business Opportunity, Global Trend, Future Growth, Key Findings and Forecast to 2023 on May 13, 2019 at 1:33 am
May 13, 2019 (The Expresswire via COMTEX) -- Global Bioelectronics and Biosensors Market by top manufacturers, type and application, with sales market share and growth rate Forecasts till 2025 The ... […]
- NeuroSigma Announces FDA Clearance of Monarch eTNS System as First Non-Drug Treatment for Pediatric ADHD on May 10, 2019 at 10:44 am
LOS ANGELES: NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric ... […]
- Bioelectronics and Biosensors Market Projected to Reach USD 28 Billion by 2024 | Hexa Research on May 7, 2019 at 1:55 am
“Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future” Hexa Research study titled “Bioelectronics and Biosensors ... […]
- BioElectronics Responds to FDA’s 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications on April 23, 2019 at 5:36 am
BioElectronics Responds to FDA's 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications FREDERICK, MD, April 23, 2019 (GLOBE NEWSWIRE) -- via ... […]
- BioElectronics Responds to FDA's 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications on April 22, 2019 at 5:00 pm
FREDERICK, MD, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com announced that the Company has submitted its response to the U.S. ... […]
- Scientific breakthrough could lead to safer bioelectronics on March 27, 2019 at 7:02 am
Not only does melanin color our skin, hair, and protect us from sun damage, it could also be used to build electronic, bionic implants, according to a recent study published in Frontiers in Chemistry. ... […]
- Bioelectronics developer Cala Health partners up with MGH against chronic diseases on March 15, 2019 at 7:46 am
Wearable bioelectronics developer Cala Health has launched a collaboration with Massachusetts General Hospital to help build out its noninvasive nerve stimulation platform for chronic diseases. In ... […]
via Bing News